Paradigm Biocapital Advisors LP: holdings and changes

Number 10 of the top 100 funds by copy return. Paradigm Biocapital Advisors LP reported 30 US stocks worth $5.0B for the quarter ending 2026-09-30 and changed 8 new, 11 added, 5 trimmed and 6 sold since 2026-06-30.

Copy return, 4 quarters+78.4%
US 500, same time+14.5%
Size$5.0B
Stocks30

Holdings

StockChangeWeightValueShares
RVMD
Revolution Medicines INC
25.38%$1.3B6,219,323
GMAB
Genmab A/S Sp Adr
ADD +8%10.03%$504M14,136,472
EWTX
Edgewise Therapeutics INC
ADD +6%8.70%$438M10,778,665
AEGLEA BIOTHER
Aeglea Biotherapeutics INC
ADD +16%7.89%$397M4,457,450
INSM
Insmed INC.
ADD +103%6.12%$308M2,695,977
MBX
Mbx Biosciences INC
ADD +50%4.40%$221M3,772,885
ORKA
Oruka Therapeutics INC
ADD +16%4.13%$208M2,493,507
BLTE
Belite Bio INC
TRIM -7%3.86%$194M1,142,123
TARS
Tarsus Pharmaceuticals INC
TRIM -17%3.60%$181M2,301,375
TNGX
Tango Therapeutics INC
ADD +10%3.45%$174M6,961,546
VRDN
Viridian Therapeutics INC
ADD +23%3.38%$170M8,257,672
BBIO
Bridgebio Pharma INC
BUY3.07%$154M2,347,850
PCVX
Vaxcyte INC
2.42%$122M2,142,852
ERAS
Erasca INC Com
TRIM -16%2.33%$117M7,998,257
JBIO
Jade Biosciences INC
ADD +112%1.69%$85M6,053,268
TYRA
Tyra Biosciences INC
ADD +92%1.53%$77M3,510,360
OLEMA PHARMACE
Olema Pharmaceut
1.50%$75M8,720,576
OBX
Obsidian Therapeutics INC
BUY1.13%$57M4,155,214
GPCR
Structure Therapeutics INC
BUY0.81%$41M1,299,199
QUIT
Achieve Life Sciences INC
0.80%$40M4,951,856
MANE
Veradermics INC
BUY0.75%$38M310,060
ASMB
Assembly Biosciences INC
0.73%$36M1,553,748
ORIC
Oric Pharmaceuticals INC
BUY0.40%$20M1,505,769
KRSA
Korsana Biosciences INC
BUY0.39%$20M613,914
EDIT
Editas Medicine INC
ADD +36%0.39%$20M7,575,140
COAG
Hemab Therapeutics Hldgs INC
BUY0.39%$19M629,347
VOR
Vor Biopharma INC
TRIM -49%0.34%$17M889,575
KARD
Kardigan INC
0.26%$13M900,000
TCGX
Tcgx Acquisition Corp
BUY0.07%$4M300,000
IVA
Inventiva Sa
TRIM -80%0.06%$3M808,176
NUVALENT INC
Nuvalent INC
SELL0%was $732M0
APOGEE THERA I
Apogee Thera INC
SELL0%was $209M0
ALNY
Alnylam Pharmaceuticals INC
SELL0%was $144M0
EYEPOINT PHARM
Eyepoint Pharmaceuticals INC
SELL0%was $41M0
MPLT
Maplight Therapeutics INC
SELL0%was $25M0
LXEO
Lexeo Therapeutics INC
SELL0%was $19M0

Copy return each quarter

HeldFund copyUS 500
2023-09-30 → 2023-12-31+29.7%+11.2%
2023-12-31 → 2024-03-31+4.2%+10.0%
2024-03-31 → 2024-06-30-14.4%+4.0%
2024-06-30 → 2024-09-30+19.1%+5.4%
2024-09-30 → 2024-12-31-8.8%+2.1%
2024-12-31 → 2025-03-31-20.2%-4.6%
2025-03-31 → 2025-06-30-1.7%+10.5%
2025-06-30 → 2025-09-30+34.7%+7.8%
2025-09-30 → 2025-12-31+22.5%+2.4%
2025-12-31 → 2026-03-31+14.9%-4.6%
2026-03-31 → 2026-06-30+28.3%+14.8%
2026-06-30 → 2026-09-30-1.2%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP